New cancer drug trial halted early – what we know
NCT ID NCT05861947
First seen Apr 24, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This early-stage study tested a new drug called AUR106 in 21 adults with advanced cancers (lung, stomach, bladder, kidney, colon, or esophagus) that had come back or spread. The main goal was to find a safe dose and check how the drug moves through the body. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
All India Institute of Medical Sciences
Bhubaneswar, Odisha, 751019, India
-
Kiran Multi Super Specialty Hospital
Surat, Gujarat, 395004, India
-
Moraya Multispeciality Hospital (Ashwin Medical Foundations)
Pune, Maharasthra, 411033, India
-
Omega Hospital
Visakhapatnam, Andhra Pradesh, 530040, India
-
Sankalp Speciality Hospital
Nashik, Maharashtra, 422009, India
-
Unique Hospital Multispeciality and Research Institute
Surat, Gujarat, 395002, India
Conditions
Explore the condition pages connected to this study.